UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of: October 2018

Commission File Number: 001- 37413

Concordia International Corp.

(Translation of registrant’s name into English)

5770 Hurontario Street, Suite 310,

Mississauga, Ontario, L5R 3G5

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

On October 1529, 2018, Concordia International Corp. (the “Corporation”) ~~issued~~announced athe ~~press~~election ~~release~~of ~~announcing~~European ~~the~~pharmaceutical ~~appointment~~industry ofexpert aMaurice ~~new~~Chagnaud ~~member~~to ofits ~~the~~ board of directors, effective November 1, 2018. In conjunction with this ~~press~~announcement ~~release~~ the Corporation is filing the following exhibit:

Exhibit 99.1 Press ~~Release~~release of Concordia International Corp., dated October 1529, 2018.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



Concordia International Corp.


By:	/s/ Adeel Ahmad
	Name:	Adeel Ahmad
	Title:	Chief Financial Officer

Date: October 1529, 2018

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press ~~Release~~release of Concordia International Corp., dated October 1529, 2018.

Filing Compare · ADVANZ PHARMA Corp.